For example, KDM4A knockdown in the human AML cell line THP1 shows a distinct increase in the H3K9me3 mark for XRCC2 and EME1 at the KDM4A site, compared to control cells. This evidence concerns the gene XRCC2 and acute myeloid leukemia.